Social anxiety disorder.
In 1990s, it was found that GSAD is more common, more disabling, and more chronic than previously realized. For the first time, there are good data about a range of effective treatment options that can offer these patients substantial relief and protection from their disability.
Raj
B A
BA
Department of Psychiatry, University of South Florida College of Medicine, Tampa, Florida, USA.
Sheehan
D V
DV
D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D001521:Behavior Therapy; D001569:Benzodiazepines; D002908:Chronic Disease; D003131:Combined Modality Therapy; D015897:Comorbidity; D003937:Diagnosis, Differential; D006801:Humans; D007406:Interview, Psychological; D008403:Mass Screening / Q000379:methods; D008960:Models, Psychological; D010698:Phobic Disorders / Q000145:classification / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D015995:Prevalence; D011569:Psychiatric Status Rating Scales; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D014481:United States / Q000453:epidemiology
D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D017367:Selective Serotonin Reuptake Inhibitors